Challenges Facing Solar Stocks
Explore the challenges and limitations faced by solar stocks, particularly First Solar, and the suggestion of alternative investment options within the industry.
Ansys Inc. in Talks for Acquisition by Synopsys Inc.
Ansys Inc. is in discussions to be acquired by Synopsys Inc., potentially forming a dominant design-software entity. The potential merger comes amidst regulatory measures and the talks are ongoing. Ansys specializes in software that predict...
AlloVir Inc. Discontinues Phase 3 Trials, Shares Plummet
AlloVir Inc. discontinues Phase 3 trials on posoleucel, resulting in a significant drop in shares. The company will redirect its focus and evaluate strategic options.
Oil Futures Rise as Concerns Over Shipping Disruptions in Red Sea Grow
The price of oil futures rose due to concerns over shipping disruptions in the Red Sea, while low water levels in the Panama Canal and diversion from the Suez Canal add challenges for global shipping. Angola's departure from OPEC raises con...
Stock Futures Down as Investors Await Inflation Data
Stock futures fall as investors await inflation data, Nike announces cost-cutting plan, athletic-gear retailers decline, Tesla hit by delivery estimate reduction, Wedbush increases price target for Tesla, Rocket Lab wins government contract...
Media Giants Warner Bros. Discovery and Paramount Discuss Possible Merger
Warner Bros. Discovery and Paramount discuss a potential merger, with uncertainties and doubts among investors. Read more to know about the possible impact on the media industry.
Paychex Stock Tumbles on Disappointing Sales, but Raises Fiscal 2024 Guidance
Shares of Paychex fell on disappointing sales, but the company raised its fiscal 2024 guidance. Despite the setback, Paychex remains optimistic and anticipates growth in the coming years.
Pariah Capital: Going Against the Grain
Pariah Capital is a contrarian hedge fund that takes inspiration from big institutional investors and invests in assets that they disdain. Learn about their unique strategy and the assets they currently favor.
Calliditas Therapeutics AB's Kidney Treatment Receives Full FDA Approval
Calliditas Therapeutics AB's Tarpeyo receives full FDA approval as the first treatment for IgAN, signaling progress in treating rare kidney diseases. Positive implications for biotech company Travere Therapeutics. Market responds well to Ca...
Artificial Intelligence: The Next Frontier in Digital Platforms
AI is set to transform digital platforms, with Amazon and Meta Platforms poised to lead the revolution. Analysts predict generative AI software revenue could reach $300 billion in the next five years. Amazon's cloud-computing business and M...